The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
rac-(3S,3'S,4'S,5'S)-6-chloro-3'-(3-chlorophenyl)-5'-[(1H-imidazol-4-yl)methyl]-4'-nitro-1,2-dihydrospiro[indole-3,2'-pyrrolidine]-2-one ID: ALA4789769
PubChem CID: 162669350
Max Phase: Preclinical
Molecular Formula: C21H17Cl2N5O3
Molecular Weight: 458.31
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=C1Nc2cc(Cl)ccc2[C@]12N[C@@H](Cc1c[nH]cn1)[C@@H]([N+](=O)[O-])[C@@H]2c1cccc(Cl)c1
Standard InChI: InChI=1S/C21H17Cl2N5O3/c22-12-3-1-2-11(6-12)18-19(28(30)31)17(8-14-9-24-10-25-14)27-21(18)15-5-4-13(23)7-16(15)26-20(21)29/h1-7,9-10,17-19,27H,8H2,(H,24,25)(H,26,29)/t17-,18-,19+,21+/m0/s1
Standard InChI Key: OHAOXDKVEPBNCW-CTAFRAEOSA-N
Molfile:
RDKit 2D
31 35 0 0 0 0 0 0 0 0999 V2000
40.3028 -4.1591 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.0732 -3.8870 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
41.0525 -3.0702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.2693 -2.8375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.8061 -3.5105 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.1094 -4.4202 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.1083 -5.2398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.8163 -5.6487 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.8145 -4.0114 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.5231 -4.4166 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.5279 -5.2352 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.3080 -5.4837 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
40.7853 -4.8186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.6025 -4.8148 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.4002 -5.6478 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
39.0931 -3.0995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.0953 -2.2756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.3832 -1.8647 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.6698 -2.2767 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.6731 -3.1039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.3858 -3.5110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.3830 -1.0475 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
39.9976 -2.0633 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
39.1942 -1.9138 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
40.5288 -1.4423 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
41.7012 -2.5733 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.4560 -2.8867 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.6470 -3.6774 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.4617 -3.7422 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
43.7751 -2.9875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.1540 -2.4563 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 1 1 0
6 7 2 0
7 8 1 0
8 11 2 0
10 9 2 0
9 6 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 1 1 0
1 10 1 6
13 14 2 0
7 15 1 0
5 16 1 1
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
18 22 1 0
23 24 2 0
23 25 1 0
4 23 1 6
3 26 1 6
26 27 1 0
27 28 2 0
28 29 1 0
29 30 1 0
30 31 2 0
31 27 1 0
M CHG 2 23 1 25 -1
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 458.31Molecular Weight (Monoisotopic): 457.0708AlogP: 3.51#Rotatable Bonds: 4Polar Surface Area: 112.95Molecular Species: NEUTRALHBA: 5HBD: 3#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.22CX Basic pKa: 6.84CX LogP: 3.11CX LogD: 3.17Aromatic Rings: 3Heavy Atoms: 31QED Weighted: 0.41Np Likeness Score: -0.38
References 1. Gollner A,Rudolph D,Arnhof H,Bauer M,Blake SM,Boehmelt G,Cockroft XL,Dahmann G,Ettmayer P,Gerstberger T,Karolyi-Oezguer J,Kessler D,Kofink C,Ramharter J,Rinnenthal J,Savchenko A,Schnitzer R,Weinstabl H,Weyer-Czernilofsky U,Wunberg T,McConnell DB. (2016) Discovery of Novel Spiro[3H-indole-3,2'-pyrrolidin]-2(1H)-one Compounds as Chemically Stable and Orally Active Inhibitors of the MDM2-p53 Interaction., 59 (22): [PMID:27775892 ] [10.1021/acs.jmedchem.6b00900 ]